retatrutide clinical trial results weight loss 2024 2025 press release New Phase 3 data just dropped 👀 Eli Lilly's reported average approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Incretin-based therapies for the treatment

The Phase 2 trial showed 22.8% average body weight reduction at 48 weeks in the 8mg group

These good results have made semaglutide a key choice in the fight against obesity

Drop your questions or let me know if youre on this journey too

At 19.0% weight loss with a lower discontinuation rate than placebo, the 4 mg dose offers a maintenance-phase option that the community has been requesting

However, these early changes may be modest and continue to develop over subsequent weeks

The ferroptosis mediated by Fe 3 O 4 -SAS @ PLT assembled by sulfasalazine (SAS) -loaded magnetic nanoparticles (Fe 3 O 4 ) and platelet (PLT) membrane can not only induce tumor-specific immune response, but also effectively repolarize immunosuppressive M2 into anti-tumor M1, regulating the anti-tumor interaction between tumor cells and macrophages (264)